Kronox Lab Sciences Ltd

Kronox Lab Sciences Ltd., a micro-cap specialty chemicals manufacturer, reported a modest quarter in Q2 FY26, with net profit rising to ₹6.68 crores—a sequential increase of 6.37% quarter-on-quarter (QoQ) and 3.24% year-on-year (YoY). With a market capitalisation of ₹546.91 crores, the Ahmedabad-based company continues to demonstrate operational resilience through strong margins, yet faces headwinds from tepid revenue growth and an increasingly bearish market sentiment. The stock closed at ₹147.40 on November 12, 2025, down 0.84% on the day, reflecting investor caution following the results announcement.

Kronox Lab Sciences, a microcap in the specialty chemicals sector, has experienced stock price fluctuations and bearish technical indicators. The company has underperformed against the Sensex over various timeframes, reflecting challenges in aligning with broader market trends and indicating a potential need for strategic adjustments.

Kronox Lab Sciences, a microcap in the specialty chemicals sector, has recently adjusted its evaluation, reflecting a change in technical outlook. The company reported a 2.60% return over the past year and a 19% increase in profits, though net sales growth has been modest at 6.80% annually over five years.

Kronox Lab Sciences, a microcap in the specialty chemicals sector, has recently revised its evaluation amid current market dynamics. The stock has seen a slight decline, with a year-to-date return significantly lower than the broader market, indicating challenges in performance and the necessity for strategic adjustments.

Kronox Lab Sciences, a microcap in the specialty chemicals sector, has encountered a technical event known as a Death Cross, indicating potential market sentiment shifts. The stock has declined significantly over the past month and year-to-date, contrasting with the Sensex's gains, while showing bearish technical indicators and a lower P/E ratio than industry peers.

Kronox Lab Sciences, a microcap in the specialty chemicals sector, has recently revised its evaluation amid challenging market conditions. The stock has shown significant volatility over the past year, underperforming compared to the Sensex. Current technical indicators present a mixed outlook, suggesting a period of consolidation.

Kronox Lab Sciences, a microcap in the specialty chemicals sector, has experienced notable stock price fluctuations, with a current price of 159.25. The company's technical indicators present a mixed outlook, and its performance has lagged behind the Sensex, reflecting challenges in the current market environment.

Kronox Lab Sciences, a microcap in the specialty chemicals sector, has recently revised its evaluation amid challenging market conditions. The company's stock has underperformed compared to the Sensex over the past year, indicating a need for strategic adjustments to improve its competitive position.

Kronox Lab Sciences, a microcap in the specialty chemicals sector, has recently seen a shift in its evaluation, reflecting changes in market sentiment. The stock's price is currently above its previous close, with notable volatility over the past year and a decline in institutional investor participation.